Hans Hammers is an Oncologist in Dallas, Texas. Dr. Hammers is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Wilms Tumor, Nephrectomy, and Thrombectomy.

Jose Karam is a Urologist in Houston, Texas. Dr. Karam is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Upper Tract Urothelial Carcinoma (UTUC), Nephrectomy, and Thrombectomy.

Surena Matin is a Urologist in Houston, Texas. Dr. Matin is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Nizar Tannir is an Oncologist and a Urologist in Houston, Texas. Dr. Tannir is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Neuroendocrine Tumor, Nephrectomy, and Orchiectomy.

Jennifer Wang is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Wang is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Upper Tract Urothelial Carcinoma (UTUC).

Lisly Chery is a Urologist in Houston, Texas. Dr. Chery has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Malakoplakia, Familial Prostate Cancer, Nephrectomy, and Prostatectomy.

Scott Thurman is a Urologist in Fort Worth, Texas. Dr. Thurman is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery.

Gregory Lieser is a Urologist in Rockwall, Texas. Dr. Lieser has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Congenital Mesoblastic Nephroma, Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Nephrectomy, and Reconstructive Urology Surgery.

Paul Bradley is a Urologist in Longview, Texas. Dr. Bradley is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Perirenal Abscess, Boils, Carbuncle, Reconstructive Urology Surgery, and Ureteroscopy.

Andrew Kirkpatrick is a Urologist in Tyler, Texas. Dr. Kirkpatrick is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Ureteroscopy, and Nephrectomy.

James Vestal is a Urologist in Arlington, Texas. Dr. Vestal has been practicing medicine for over 40 years and is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Revathi Angitapalli is a Hematologist and an Oncologist in Arlington, Texas. Dr. Angitapalli has been practicing medicine for over 26 years and is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Chromophobe Renal Cell Carcinoma, and Clear Cell Sarcoma.

Keith Waguespack is a Urologist in Irving, Texas. Dr. Waguespack is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Clear Cell Sarcoma, Nephrectomy, and Reconstructive Urology Surgery.

Aravind Sanjeevaiah is a Hematologist and an Oncologist in Waxahachie, Texas. Dr. Sanjeevaiah has been practicing medicine for over 23 years and is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Colorectal Cancer, Stomach Cancer, Neuroendocrine Tumor, and Gastrointestinal Stromal Tumor.

Shivani Patel is a Hematologist Oncology specialist and a Hematologist in Houston, Texas. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Familial Colorectal Cancer.

Jenny Pozadzides is a Hematologist and an Oncologist in Houston, Texas. Dr. Pozadzides is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Neuroendocrine Tumor.

Dr. Buddima Ranasinghe is a board-certified urologist with specialized training in the use of robotic-assisted technology for urologic care. His areas of clinical focus include general and laparoscopic urologic surgeries, bladder and prostate health, and treatment of adrenal masses. In 2019, Dr. Ranasinghe began serving as a staff urologist within the Henry Ford Health System in Jackson, Mich. Prior to that time, he spent six years in general surgery and urology at Maimonides Medical Center in Brooklyn.Dr. Ranasinghe earned his medical degree at State University of New York Downstate Medical Center in New York City. He went on to complete his urology residency at Maimonides Medical Center in Brooklyn before completing a robotic urologic fellowship at The Vattikuti Urology Institute at Henry Ford Health System in Detroit, Mich. Dr. Ranasinghe is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Obstructive Uropathy, Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Ureteroscopy, and Reconstructive Urology Surgery.

Dr. Aihua Edward Yen is an oncologist specializing in genitourinary medical oncology. He is an Assistant Professor of Medicine - Hematology and Oncology at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine (BCM). He is also an Instructor of Medicine - Hematology and Oncology Section at BCM and a Urology Oncology specialist at the Bladder Cancer Center at BCM’s Dan L Duncan Comprehensive Cancer Center.Dr. Yen’s clinical interests include: prostate cancer and genitourinary cancers.Dr. Yen received his medical degree from Baylor College of Medicine, where he also completed his residency in internal medicine and a fellowship in hematology and medical oncology.Dr. Yen is board-certified in Medical Oncology by the American Board of Internal Medicine. In addition to English, Dr. Yen speaks Mandarin. Dr. Yen is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, and Non-Muscle Invasive Bladder Cancer.

Richard E. Link, M.D., Ph.D., Associate Professor, is a Board-certified and fellowship-trained urologist specializing in the treatment of urologic disease affecting the kidney, ureter, and prostate. He focuses on the use of laparoscopic, robotic-assisted, percutaneous, and endoscopic techniques to treat kidney tumors, renal and ureteral obstruction, and urinary tract stones. He directs the BCM Division of Endourology and Minimally Invasive Surgery and is active, nationally, in teaching these techniques to other urologists through the American Urological Association Office of Education. He has also directed the BCM fellowship program in Minimally Invasive Urologic Surgery since 2008. Dr. Link has been an early pioneer in the development of laparoendoscopic single-site donor nephrectomy, a less invasive laparoscopic technique in which a donor kidney can be removed via only a single, small peri-umbilical incision for transplantation. He serves as Director of Living Donor Procurement for several major kidney transplant programs in Houston, including CHI/SLEH/BCM, Texas Children's Hospital, and the Houston Methodist Hospital. He also co-directs the BCM Comprehensive Stone Clinic, which provides a state-of-the-art multidisciplinary tertiary referral center for patients with complex kidney stones. Dr. Link completed his Ph.D. in Molecular and Cellular Physiology at Stanford University. His research laboratory studies the genetic basis for renal cell carcinoma and urinary tract stone disease using a combination of genetically engineered mouse models, stem cell biology, and sophisticated whole genome molecular techniques. His clinical research interests include surgical simulation, decision analysis modeling, and the application of 3D reconstruction and printing techniques to surgical education. Dr. Link is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Wilms Tumor, Clear Cell Sarcoma, Nephrectomy, and Reconstructive Urology Surgery.

Matthew Shuford is a Urologist in Dallas, Texas. Dr. Shuford is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery.